Zephirus

Zephirus combines budesonide and salmeterol for inhaled respiratory relief. This combination therapy is designed to manage symptoms associated with asthma and COPD. Suitable for adults and children over 12 years. Always follow prescribed guidance.

Zephirus is used to control and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). It combines an inhaled corticosteroid (budesonide) to reduce inflammation and a long-acting beta agonist (salmeterol) to open airways. This dual-action approach helps maintain steady breathing and reduce flare-ups in respiratory conditions.

Users may experience improved breathing and reduced wheezing or shortness of breath shortly after use. The medication works gradually to control inflammation in the lungs, which can help minimize the frequency of asthma attacks or COPD exacerbations. Effects vary by individual and consistent use is important for best results.

Store Zephirus in a cool, dry place away from direct sunlight. Keep the inhaler clean and dry to ensure proper function. Always check the mouthpiece for debris before use. If you experience worsening symptoms or side effects, consult a healthcare provider promptly. Do not use expired medication.

Zephirus may interact with other inhaled medications or systemic corticosteroids. Avoid combining with strong CYP3A4 inhibitors, as these can increase the risk of side effects. Alcohol and certain foods do not typically interact, but always inform your healthcare provider about all medications and supplements you are taking.